Your browser doesn't support javascript.
loading
Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Hogan, Molly P; Horvat, Joao V; Ross, Dara S; Sevilimedu, Varadan; Jochelson, Maxine S; Kirstein, Laurie J; Goldfarb, Shari B; Comstock, Christopher E; Sung, Janice S.
Affiliation
  • Hogan MP; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Horvat JV; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. machadoj@mskcc.org.
  • Ross DS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Sevilimedu V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10017, USA.
  • Jochelson MS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Kirstein LJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Goldfarb SB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Comstock CE; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Sung JS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Breast Cancer Res Treat ; 198(2): 349-359, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36754936
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Observational_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Observational_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article